Abstract |
Experiments were designed to test the hypothesis that activation of forebrain 5-HT1A receptors elicits cardiovascular responses. The microinjection of R-(+)-8-hydroxy-2-(di-n-propylamino) tetralin [(+)-8- OH-DPAT], a selective 5-HT1A receptor agonist, in the preoptic area of conscious rats increased blood pressure and heart rate at doses of 0.2-20 nmol; lower doses (0.002 and 0.02 nmol) were ineffective. The concomitant administration of methiothepin, a non-selective 5-HT receptor antagonist, into the preoptic area attenuated the responses. In addition, the tachycardia elicited by (+)-8- OH-DPAT was abolished by the peripheral beta-adrenoceptor antagonist sotalol, but not by atropine methyl nitrate. Finally, the tachycardia, but not the hypertension, was also produced by (+)-8- OH-DPAT in urethane-anesthetized rats. These results suggest that activation of 5-HT1A receptors in the preoptic area or an adjacent region of the forebrain produces: (1) an increase in heart rate consistent with sympathoadrenal activation; and (2) an increase in blood pressure which might be the result of sympathoexcitation or secondary to behavioral arousal.
|
Authors | A Szabó, M Bowman, C J Braun, R H Alper |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 315
Issue 2
Pg. 187-94
(Nov 14 1996)
ISSN: 0014-2999 [Print] Netherlands |
PMID | 8960883
(Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Parasympatholytics
- Receptors, Serotonin
- Receptors, Serotonin, 5-HT1
- Serotonin Antagonists
- Methiothepin
- 8-Hydroxy-2-(di-n-propylamino)tetralin
- Atropine
|
Topics |
- 8-Hydroxy-2-(di-n-propylamino)tetralin
(administration & dosage, pharmacology)
- Animals
- Atropine
(pharmacology)
- Hemodynamics
(drug effects)
- Male
- Methiothepin
(pharmacology)
- Microinjections
- Parasympatholytics
(pharmacology)
- Preoptic Area
- Rats
- Rats, Sprague-Dawley
- Receptors, Serotonin
(drug effects)
- Receptors, Serotonin, 5-HT1
- Serotonin Antagonists
(administration & dosage, pharmacology)
|